Fluvastatin in the Therapy of Acute Coronary Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

February 28, 2007

Conditions
Coronary DiseaseMyocardial Infarction
Interventions
DRUG

Fluvastatin

Trial Locations (1)

Unknown

Novartis, Prague

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Ministry of Health, Czech Republic

OTHER_GOV

lead

Novartis

INDUSTRY

NCT00171275 - Fluvastatin in the Therapy of Acute Coronary Syndrome | Biotech Hunter | Biotech Hunter